NCT06003686 Spinal Cord Injury Model Systems (SCIMS) - Education Module
| NCT ID | NCT06003686 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-03-05 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2024-03-05 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.
Eligibility Criteria
Inclusion Criteria: 1. Men and Women with SCI/D aged 18-70 years. 2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below. 3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI. Exclusion Criteria: 1. Pregnancy determined by urine testing in sexually active females. 2. Cognitive impairment that compromises the legitimacy of consent. 3. Grade 3-4 pressure injury at the time of study entry. 4. Prisoners
Contact & Investigator
Gary Farkas, PhD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06003686 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06003686 currently recruiting?
Yes, NCT06003686 is actively recruiting participants. Contact the research team at pgraham1@med.miami.edu for enrollment information.
Where is the NCT06003686 trial being conducted?
This trial is being conducted at Washington D.C., United States, Miami, United States, Dallas, United States.
Who is sponsoring the NCT06003686 clinical trial?
NCT06003686 is sponsored by University of Miami. The principal investigator is Gary Farkas, PhD at University of Miami. The trial plans to enroll 250 participants.